LEADER 01436nam--2200421---450- 001 990000655580203316 005 20090831122016.0 010 $a88-14-02820-6 035 $a0065558 035 $aUSA010065558 035 $a(ALEPH)000065558USA01 035 $a0065558 100 $a20011001d1991----km-y0ITAy01------ba 101 $aita 102 $aIT 105 $a00||| 200 1 $aGiurisprudenza tributaria di merito$edecisioni delle commissioni tributarie di merito commentate e coordinate, 1989-1990$fa cura di Alfredo Arienzo, Virgilio Amato, Ettore Protettì 210 $aMilano$cA. Giuffrè$d1991 215 $a888 p.$d25 cm 312 $aTit. sul dorso: Giurisprudenza tributaria di merito 1989-1990 606 $aTributi$xGiurisprudenza$z1989-1990 676 $a343.4504 702 1$aARIENZO,$bAlfredo 702 1$aAMATO,$bVirgilio 702 1$aPROTETTI,$bEttore 801 0$aIT$bsalbc$gISBD 912 $a990000655580203316 951 $aXXIV.5.A 47 (IG VII 305/1989-1990)$b72772 E.C.$cXXIV.5.A 47 (IG VII)$d00242177 959 $aBK 969 $aGIU 979 $aPATTY$b90$c20011001$lUSA01$h1217 979 $aPATTY$b90$c20011001$lUSA01$h1231 979 $aPATTY$b90$c20011001$lUSA01$h1241 979 $c20020403$lUSA01$h1715 979 $aPATRY$b90$c20040406$lUSA01$h1645 979 $aRSIAV4$b90$c20090831$lUSA01$h1220 996 $aGiurisprudenza tributaria di merito$961216 997 $aUNISA LEADER 02013nam 2200565 a 450 001 9910461299703321 005 20200520144314.0 010 $a1-61324-472-X 035 $a(CKB)2670000000095650 035 $a(EBL)3019682 035 $a(SSID)ssj0000522128 035 $a(PQKBManifestationID)12230601 035 $a(PQKBTitleCode)TC0000522128 035 $a(PQKBWorkID)10527764 035 $a(PQKB)10950499 035 $a(MiAaPQ)EBC3019682 035 $a(Au-PeEL)EBL3019682 035 $a(CaPaEBR)ebr10671247 035 $a(OCoLC)738478405 035 $a(EXLCZ)992670000000095650 100 $a20090820d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDrug monitoring by HPLC$b[electronic resource] $erecent developments /$fVictoria Samanidou and Eftichia Karageorgou 210 $aNew York $cNova Science Publishers$dc2010 215 $a1 online resource (137 p.) 225 1 $aPharmacology : research, safety testing and regulation series 300 $aDescription based upon print version of record. 311 $a1-60876-183-5 320 $aIncludes bibliographical references and index. 327 $aBrief introduction to HPLC -- Sample preparation -- Anti-cancer drugs -- Bronchodilators -- Cardiovascular drugs -- Antipsychotics -- Antibiotics -- Antiepileptic drugs -- Antidepressants -- Immunosuppressants. 410 0$aPharmacology-research, safety testing, and regulation series. 606 $aHigh performance liquid chromatography 606 $aDrugs$xAnalysis 608 $aElectronic books. 615 0$aHigh performance liquid chromatography. 615 0$aDrugs$xAnalysis. 676 $a615/.1901 700 $aSamanidou$b Victoria$0930640 701 $aKarageorgou$b Eftichia$0930641 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910461299703321 996 $aDrug monitoring by HPLC$92093350 997 $aUNINA